Arbutus Biopharma's chart data is dated 2026-10-09. Recorded technical signals: RSI rebound. There are 3 published signal records.
Arbutus Biopharma last closed at $4.22 (+0.96%) on 2026-10-09. Signals today: RSI rebound. Listed on Nasdaq. Trailing 12 months PER is 5.4×. Its overall grade ranks 286 of 738 stocks in Healthcare.
About this company
Arbutus Biopharma last closed at $4.22 (+0.96%) on 2026-10-09. Signals today: RSI rebound. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B+ · 286/738
Valuation grade B+
Related stocks
- ModernaCompetitor
HBV 치료제 및 mRNA 기반 감염병 파이프라인에서 경쟁
- Gilead SciencesCompetitor
B형간염 치료제 개발 및 항바이러스 분야의 주요 경쟁사
- Vir BiotechnologyCompetitor
만성 B형간염 등 항바이러스 치료제 개발 경쟁
ETFs holding this stock
First Trust Dow Jones Select MicroCap Index Fund
Details →About Arbutus Biopharma
- What technical signals does Arbutus Biopharma (ABUS) have?
- Arbutus Biopharma current technical signals: RSI rebound.
- Is Arbutus Biopharma a cup-and-handle pattern?
- No. Arbutus Biopharma has no valid Cup signal right now.
- What published figures are available for Arbutus Biopharma?
- Market cap: $811.61M. Trailing 12 months PER: 5.4×. Latest quarter PBR: 3.19×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Arbutus Biopharma, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.